Tower Research Capital LLC (Trc) United Therapeutics Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in United Therapeutics Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,251 shares of UTHR stock, worth $454,425. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,251
Previous 1,004
24.6%
Holding current value
$454,425
Previous $319,000
40.44%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding UTHR
# of Institutions
667Shares Held
42.7MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.99 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.6 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.15 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.04 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$813 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...